© 2023 Kindbody

Contact Us Today


Welcome to Kindlabs

At Kindbody, our mission is clear: Improve the accuracy of reproductive healthcare to maximize the likelihood of healthy live births. Every decision we make, every technology we embrace, and every innovation at Kindlabs is driven by this guiding principle.

Preimplantation Genetic Testing (PGT-A)

Advanced PGT-A Testing

Our advanced PGT-A testing evaluates embryos' genetic condition before transfer, improving pregnancy outcomes.

Selecting Healthiest Embryos

Choose the healthiest embryos for successful implantation, minimizing miscarriage and genetic disorder risks.

Enhanced Accuracy with NGS

Next-Generation Sequencing (NGS) at Kindlabs provides enhanced accuracy and actionable results for our patients.

Ready to take the next step towards parenthood?

Schedule a consultation with our dedicated doctors at Kindbody. Our patient’s pregnancy outcomes are empowered by our in-house PGT-A testing program, Kindlabs.

Book Consult

Vice President of Preimplantation Genetic Testing (PGT) and Clinical Laboratory Director

Chief Medical Officer of Genomics and Laboratory Sciences

Meet Our Kindlabs Leadership

Comprehensive Care

By incorporating Kindlabs into our comprehensive portfolio of services, Kindbody extends its commitment to addressing clinical infertility. Our dedicated team of specialists, led by our renowned lab directors, works collaboratively to provide personalized care and support at every step of your fertility journey. Whether you're a referring provider or a patient, choosing Kindbody means selecting a partner that offers advanced technology, unmatched expertise, and a compassionate approach to reproductive healthcare.

Quality Assurance and Accreditation

We understand the importance of trust and reliability when it comes to your reproductive journey. That's why Kindlabs maintains the highest standards of quality assurance and has obtained prestigious certifications. We are certified by the Clinical Laboratory Improvement Amendments (CLIA) and are enrolled in the accreditation program of the College of American Pathologists (CAP). This accreditation is widely recognized as the gold standard for molecular diagnostics, ensuring that you receive the most accurate and reliable results.

Unparalleled Technology

Kindlabs utilizes state-of-the-art technology that surpasses many third-party PGT systems. Our advanced sequencing technology provides an average of eight times more sequencing information per sample compared to commonly used PGT platforms. This unparalleled level of detail enables our laboratory experts to deliver highly precise outcomes, increasing the likelihood of a successful pregnancy.

The Kindlabs Difference

Precise PGT for 
Your Path to Parenthood

PGT-A stands for Preimplantation Genetic Testing for Aneuploidy. It is a procedure that assesses the genetic condition of embryos before they are transferred into the uterus.

During PGT-A, a small sample of cells is extracted from embryos at the blastocyst stage, usually 5-7 days after fertilization. These cells are then analyzed to determine if they exhibit the correct number of chromosomes.

Aneuploidy refers to deviations in the chromosome count, such as the presence of extra or missing chromosomes. PGT-A helps identify genetic abnormalities and aneuploidies in embryos.

By conducting PGT-A, fertility specialists can select the healthiest embryos for transfer, significantly improving the chances of successful implantation. It also helps minimize the risks of miscarriage and genetic disorders.

Kindlabs'Next-Generation Sequencing (NGS)-based PGT-A platform generates eight times more data per sample compared to most commercially available tests. This leads to enhanced accuracy and provides more actionable results for our patients.

Our advanced PGT-A testing evaluates embryos' genetic condition before transfer, helping us select the healthiest embryos. This optimization improves pregnancy outcomes and increases the chances of a successful pregnancy.

Your Questions Answered

Generates up to eight times the amount of genetic data per sample1

Fewer samples with
inconclusive or no results2 

Identifies smaller chromosomal segmental losses and gains3

The Kindlabs Difference

1Compared to advertised depth of sequencing used in common PGT-A platforms 
2Internal data analysis from Kindbody clinical samples sent to reference laboratories 
3Validation data shows identification of segmental losses/gains down to 1Mb (compared to the advertised 10Mb or 20Mb for most of third party reference laboratories)

Superior precision in intermediate copy number determination – accurate mosaicism

Integrated with Kindbody workflows for perfect sample tracking

CLIA certified, CAP accredited,
and proficiency testing program by AAB (industry gold standard)